DocMorris AG

BATS-CHIXE:DOCMZ Stock Report

Market Cap: CHF 320.5m

DocMorris Valuation

Is DOCMZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DOCMZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Fair Value: Insufficient data to calculate DOCMZ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate DOCMZ's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DOCMZ?

Key metric: As DOCMZ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for DOCMZ. This is calculated by dividing DOCMZ's market cap by their current revenue.
What is DOCMZ's PS Ratio?
PS Ratio0.3x
SalesCHF 1.06b
Market CapCHF 320.51m

Price to Sales Ratio vs Peers

How does DOCMZ's PS Ratio compare to its peers?

The above table shows the PS ratio for DOCMZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
KITW Kitwave Group
0.3x5.11%UK£190.1m
CBOX Cake Box Holdings
1.7x13.94%UK£92.4m
WINE Naked Wines
0.2x-8.07%UK£52.2m
VINO Virgin Wines UK
0.5x9.23%UK£30.2m
DOCMZ DocMorris
0.3x13.05%CHF 320.5m

Price-To-Sales vs Peers: DOCMZ is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.7x).

Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Sales Ratio vs Industry

How does DOCMZ's PS Ratio compare vs other companies in the European Consumer Retailing Industry?

9 CompaniesPrice / SalesEstimated GrowthMarket Cap
No. of Companies10PS00.40.81.21.62+
9 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: DOCMZ is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Consumer Retailing industry average (0.4x).

Price to Sales Ratio vs Fair Ratio

What is DOCMZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DOCMZ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio0.4x

Price-To-Sales vs Fair Ratio: DOCMZ is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DOCMZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 6.64
CHF 9.38
+41.23%
30.70%CHF 15.00CHF 5.50n/a9
Dec ’26CHF 5.55
CHF 11.94
+115.33%
68.32%CHF 35.00CHF 5.50n/a10
Nov ’26CHF 5.54
CHF 11.94
+115.72%
68.32%CHF 35.00CHF 5.50n/a10
Oct ’26CHF 5.81
CHF 12.89
+121.84%
64.57%CHF 35.00CHF 5.90n/a9
Sep ’26CHF 6.68
CHF 12.89
+92.95%
64.57%CHF 35.00CHF 5.90n/a9
Aug ’26CHF 7.78
CHF 14.48
+86.24%
53.49%CHF 35.00CHF 8.00n/a10
Jul ’26CHF 6.77
CHF 17.89
+164.27%
56.19%CHF 40.00CHF 8.00n/a11
Jun ’26CHF 8.52
CHF 19.92
+133.89%
47.29%CHF 40.00CHF 9.36n/a10
May ’26CHF 23.04
CHF 30.60
+32.81%
43.82%CHF 60.00CHF 17.00n/a10
Apr ’26CHF 17.57
CHF 34.82
+98.17%
41.98%CHF 60.00CHF 17.00n/a11
Mar ’26CHF 21.00
CHF 35.17
+67.46%
40.45%CHF 60.00CHF 16.00n/a12
Feb ’26CHF 19.95
CHF 35.92
+80.03%
37.33%CHF 60.00CHF 20.00n/a12
Jan ’26CHF 20.04
CHF 46.92
+134.12%
31.89%CHF 75.00CHF 25.00CHF 5.9512
Dec ’25CHF 30.06
CHF 52.33
+74.10%
33.60%CHF 90.00CHF 25.00CHF 5.5512
Nov ’25CHF 34.82
CHF 52.50
+50.78%
33.25%CHF 90.00CHF 25.00CHF 5.5412
Oct ’25CHF 36.98
CHF 65.92
+78.25%
39.96%CHF 125.00CHF 27.00CHF 5.8112
Sep ’25CHF 38.72
CHF 78.00
+101.45%
35.46%CHF 125.00CHF 27.00CHF 6.6812
Aug ’25CHF 44.46
CHF 88.50
+99.06%
28.23%CHF 125.00CHF 29.00CHF 7.7812
Jul ’25CHF 52.90
CHF 98.58
+86.36%
26.28%CHF 130.00CHF 29.00CHF 6.7712
Jun ’25CHF 67.15
CHF 99.24
+47.79%
25.51%CHF 130.00CHF 31.90CHF 8.5212
May ’25CHF 82.90
CHF 99.24
+19.71%
25.51%CHF 130.00CHF 31.90CHF 23.0412
Apr ’25CHF 90.85
CHF 88.91
-2.14%
26.48%CHF 115.00CHF 29.00CHF 17.5711
Mar ’25CHF 78.05
CHF 77.92
-0.17%
28.77%CHF 105.00CHF 29.00CHF 21.0012
Feb ’25CHF 79.05
CHF 77.92
-1.43%
28.77%CHF 105.00CHF 29.00CHF 19.9512
Jan ’25CHF 73.45
CHF 69.00
-6.06%
31.95%CHF 102.00CHF 29.00CHF 20.0412
CHF 9.44
Fair Value
29.7% undervalued intrinsic discount
9
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/06 09:49
End of Day Share Price 2026/01/06 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DocMorris AG is covered by 18 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Sarah RobertsBarclays
Gerhard OrgonasBerenberg